Department of Chemistry, Amirkabir University of Technology, P.O. Box 1587-4413, Tehran, Iran.
Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI, 48109.
J Biomed Mater Res A. 2018 Feb;106(2):349-359. doi: 10.1002/jbm.a.36242. Epub 2017 Oct 12.
5-Fluorouracil (5-Fu) commonly use in the treatment of different kinds of cancer, but limited cellular uptake and death is still a problem. Herein, we report a simple process for the synthesis of pressure-sensitive nanogels that indicate to be appropriate in the delivery of 5-Fu. The hydrogels (Al-CD) prepare by crosslinking of alginate (Al) with modified beta Cyclodextrin (β-CD) as Crosslinker. Next, nanoparticles obtaine by an emulsification method. 5-Fu as model drug loades into the Al-CD nanogels easily by mixing it in aqueous solution with the nanoparticles. The results revealed that the Al-CD nanogels are cytocompatible. They have also a noticeable drug encapsulation (82.1 ±5.7%) while they can release (in vitro controlled) 5-Fu in conditions that imitate the intravascular pressure conditions. These nanogels can rapidly be taken up by HT-29 cells (a colon cell line). In addition, a higher 5-Fu intracellular accumulation and a significant cell death extension by apoptosis mechanism is notice when compare with free 5-Fu. Accordingly, the developed nanogels can be employe as an excellent candidate to overcome the inefficiency of 5-Fu in anticancer treatments and possibly can employe for further evaluation as a chemotherapical agent in applications beyond cancer. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 106A: 349-359, 2018.
5-氟尿嘧啶(5-Fu)常用于治疗各种癌症,但细胞摄取和死亡仍然是一个问题。本文报道了一种简单的合成压力敏感纳米凝胶的方法,该凝胶可用于 5-Fu 的递送。通过海藻酸钠(Al)与改性β环糊精(β-CD)交联制备水凝胶(Al-CD)作为交联剂。然后,通过乳化法获得纳米颗粒。将 5-Fu 作为模型药物通过将其与纳米颗粒在水溶液中混合很容易载入到 Al-CD 纳米凝胶中。结果表明,Al-CD 纳米凝胶具有细胞相容性。它们还具有显著的药物包封(82.1±5.7%),同时可以在模拟血管内压力条件下(体外控制)释放 5-Fu。这些纳米凝胶可以被 HT-29 细胞(结肠细胞系)迅速摄取。此外,与游离 5-Fu 相比,通过细胞凋亡机制观察到细胞内 5-Fu 积累增加和细胞死亡显著延长。因此,开发的纳米凝胶可作为克服 5-Fu 在癌症治疗中效率低下的优秀候选物,并可能进一步评估为癌症治疗以外的化疗药物。 © 2017 威利父子公司。J 生物医学材料 Res 部分 A:106A:349-359,2018 年。
J Biomed Mater Res A. 2017-10-12
Mater Sci Eng C Mater Biol Appl. 2017-1-1
Colloids Surf B Biointerfaces. 2017-12-28
Colloids Surf B Biointerfaces. 2016-3-1
Langmuir. 2008-4-15
Int J Pharm. 2012-3-2
Hum Vaccin Immunother. 2025-12
Int J Mol Sci. 2023-4-27
ACS Appl Bio Mater. 2023-5-15
Recent Adv Drug Deliv Formul. 2022
Front Chem. 2022-9-14